α-Azido Bisphosphonates: Synthesis and Nucleotide AnaloguesCHAMBERLAIN, Brian T; UPTON, Thomas G; KASHEMIROV, Boris A et al.Journal of organic chemistry. 2011, Vol 76, Num 12, pp 5132-5136, issn 0022-3263, 5 p.Article

Nanoencapsulation of antiviral nucleotide analogsHILLAIREAU, H; COUVREUR, P.Journal of drug delivery science and technology. 2009, Vol 19, Num 6, pp 385-390, issn 1773-2247, 6 p.Article

Fludarabine-induced severe necrotizing leukoencephalopathy in pediatric hematopoietic cell transplantationHELTON, K. J; PATAY, Z; TRIPLETT, B. M et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 5, pp 729-731, issn 0268-3369, 3 p.Article

Single-Dose Pharmacokinetics of Cidofovir in Continuous Venovenous HemofiltrationVOSSEN, Matthias G; GATTRINGER, Klaus-Bernhard; JÄGER, Walter et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 4, pp 1952-1955, issn 0066-4804, 4 p.Article

The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosidesMAGEE, Wendy C; EVANS, David H.Antiviral research. 2012, Vol 96, Num 2, pp 169-180, issn 0166-3542, 12 p.Article

GS-9191 Is a Novel Topical Prodrug of the Nucleotide Analog 9-(2-Phosphonylmethoxyethyl)Guanine with Antiproliferative Activity and Possible Utility in the Treatment of Human Papillomavirus LesionsWOLFGANG, Grushenka H. I; SHIBATA, Riri; ANDREI, Graciela et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 7, pp 2777-2784, issn 0066-4804, 8 p.Article

Deoxyuridine analog nucleotides in deoxycytidine analog treatment: secondary active metabolites?JANSEN, Robert S; ROSING, Hilde; SCHELLENS, Jan Hm et al.Fundamental & clinical pharmacology. 2011, Vol 25, Num 2, pp 172-185, issn 0767-3981, 14 p.Article

Pre-Steady-State Kinetic Analysis of the Incorporation of Anti-HIV Nucleotide Analogs Catalyzed by Human X- and Y-Family DNA PolymerasesBROWN, Jessica A; PACK, Lindsey R; FOWLER, Jason D et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 1, pp 276-283, issn 0066-4804, 8 p.Article

Nucleoside and Nucleotide Analogs Select in Culture for Different Patterns of Drug Resistance in Human Immunodeficiency Virus Types 1 and 2NTEMGWA, Michel L; D'AQUIN TONI, Thomas; BRENNER, Bluma G et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 2, pp 708-715, issn 0066-4804, 8 p.Article

Stable long-term pulmonary function after fludarabine, antithymocyte globulin and i.v. BU for reduced-intensity conditioning allogeneic SCTDIROU, S; MALARD, F; MOHTY, M et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 5, pp 622-627, issn 0268-3369, 6 p.Article

Minimizing Surgical Management Through the Use of Adjuvant Medical TherapiesCAVEL, Oren; AYARI, Sonia; COULOMBEAU, Bruno et al.The Laryngoscope. 2012, Vol 122, issn 0023-852X, S99-S100, SUP4Conference Paper

Blanc ou rouge, il fallait choisir.. = Bullous skin rash in a 61-year-old manPHELIPPEAU, M; BONNET, D; LAURENTY, A.-P et al.La Revue de médecine interne (Paris). 2011, Vol 32, Num 2, pp 120-123, issn 0248-8663, 4 p.Article

High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantationLONG-BOYLE, J. R; GREEN, K. G; BRUNSTEIN, C. G et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 1, pp 20-26, issn 0268-3369, 7 p.Article

Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractorinessROSSI, Davide; BRUSCAGGIN, Alessio; GUARINI, Anna et al.Blood. 2011, Vol 118, Num 26, pp 6904-6908, issn 0006-4971, 5 p.Article

Oral fludarabine in untreated patients with B-cell chronic lymphocytic leukemiaSHUSTIK, C; TURNER, A. R; LI, D et al.Leukemia. 2010, Vol 24, Num 1, pp 237-239, issn 0887-6924, 3 p.Article

Targeting base excision repair suggests a new therapeutic strategy of fludarabine for the treatment of chronic lymphocytic leukemiaBULGAR, A. D; SNELL, M; DONZE, J. R et al.Leukemia. 2010, Vol 24, Num 10, pp 1795-1799, issn 0887-6924, 5 p.Article

Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimenBOLANOS-MEADE, J; LUZNIK, L; BRODSKY, R. A et al.Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 6, pp 477-480, issn 0268-3369, 4 p.Article

Effects of Mutagenic and Chain-Terminating Nucleotide Analogs on Enzymes Isolated from Hepatitis C Virus Strains of Various GenotypesHECK, Julie A; LAM, Angela M. I; NARAYANAN, Nirupama et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 6, pp 1901-1911, issn 0066-4804, 11 p.Article

Application of the cycloSal-prodrug approach for improving the biological potential of phosphorylated biomoleculesMEJER, C; BAIZARINI, J.Antiviral research. 2006, Vol 71, Num 2-3, pp 282-292, issn 0166-3542, 11 p.Article

Allogeneic transplantation after reduced-intensity conditioning with fludarabine-CY for both indolent and aggressive lymphoid malignanciesWONDERGEM, M. J; DIJKSTRA, F. S; VISSER, O. J et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 4, pp 513-518, issn 0268-3369, 6 p.Article

Incomplete Reversibility of Estimated Glomerular Filtration Rate Decline Following Tenofovir Disoproxil Fumarate ExposureJOSE, Sophie; HAMZAH, Lisa; JOHNSON, Margaret et al.The Journal of infectious diseases. 2014, Vol 210, Num 3, pp 363-373, issn 0022-1899, 11 p.Article

Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemiaROSSI, Davide; FANGAZIO, Marco; SPINA, Valeria et al.Blood. 2012, Vol 119, Num 12, pp 2854-2862, issn 0006-4971, 9 p.Article

Alternative donor marrow transplantation in children with aplastic anemia using low-dose irradiation and fludarabine-based conditioningYABE, M; SHIMIZU, T; MORIMOTO, T et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 8, pp 1148-1150, issn 0268-3369, 3 p.Article

Fludarabine-based reduced intensity conditioning transplants have a higher incidence of cytomegalovirus reactivation compared with myeloablative transplantsGEORGE, B; KERRIDGE, I; GILROY, N et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 5, pp 849-855, issn 0268-3369, 7 p.Article

R-DHAP is effective in fludarabine-refractory chronic lymphocytic leukemiaTONINO, S. H; VAN GELDER, M; ELDERING, E et al.Leukemia. 2010, Vol 24, Num 3, pp 652-654, issn 0887-6924, 3 p.Article